BREXUCABTAGENE AUTOLEUCEL for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 41 adverse event reports in the FDA FAERS database where BREXUCABTAGENE AUTOLEUCEL was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for BREXUCABTAGENE AUTOLEUCEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 827 | 47.3% | 168 | 436 |
| Immune effector cell-associated neurotoxicity syndrome | 529 | 30.3% | 123 | 291 |
| Neurotoxicity | 192 | 11.0% | 32 | 96 |
| Death | 153 | 8.8% | 153 | 20 |
| Pyrexia | 119 | 6.8% | 15 | 77 |
| Hypotension | 109 | 6.2% | 27 | 63 |
| Disease progression | 93 | 5.3% | 44 | 13 |
| Fatigue | 86 | 4.9% | 10 | 28 |
| Febrile neutropenia | 69 | 4.0% | 4 | 63 |
| Confusional state | 63 | 3.6% | 12 | 36 |
| Encephalopathy | 53 | 3.0% | 14 | 32 |
| Myelodysplastic syndrome | 51 | 2.9% | 15 | 6 |
| Squamous cell carcinoma of skin | 50 | 2.9% | 6 | 0 |
| Tachycardia | 49 | 2.8% | 14 | 18 |
| Tremor | 49 | 2.8% | 2 | 20 |
Other Indications for BREXUCABTAGENE AUTOLEUCEL
Mantle cell lymphoma (696)
Product used for unknown indication (359)
Acute lymphocytic leukaemia (223)
Non-hodgkin's lymphoma (126)
B-cell type acute leukaemia (55)
Mantle cell lymphoma recurrent (34)
Mantle cell lymphoma refractory (34)
Burkitt's lymphoma (19)
Acute lymphocytic leukaemia recurrent (13)
Mantle cell lymphoma stage iv (13)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)